Q2 2026 Holdings
Filed 2026-08-06 | 15 holdings | $798.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $300.2M | 2,449,183 | 37.6% |
| Nanobiotix(NBTX) | SPONSORED ADS | 63009J107 | $212.0M | 5,623,816 | 26.5% |
| Meiragtx Hldgs PLC(MGTX) | COM | G59665102 | $89.7M | 6,641,064 | 11.2% |
| Rapport Therapeutics Inc(RAPP) | COM | 75383L102 | $74.4M | 1,784,517 | 9.3% |
| Contineum Therapeutics Inc(CTNM) | CL A | 21217B100 | $32.4M | 1,979,173 | 4.1% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $23.5M | 814,586 | 2.9% |
| Cvrx Inc(CVRX) | COM | 126638105 | $20.7M | 4,024,861 | 2.6% |
| Xencor Inc(XNCR) | COM | 98401F105 | $12.0M | 748,062 | 1.5% |
| Cerebras Systems Inc(CBRS) | COM CL A | 15675D103 | $11.8M | 53,586 | 1.5% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $9.1M | 3,379,064 | 1.1% |
| Procept Biorobotics Corp(PRCT) | COM | 74276L105 | $8.1M | 357,939 | 1.0% |
| Neumora Therapeutics Inc.(NMRA) | COM | 640979100 | $3.1M | 1,849,445 | 0.4% |
| VOR Biopharma Inc(VOR) | COM NEW | 929033207 | $989.2K | 53,732 | 0.1% |
| Standard Biotools Inc(LAB) | COM | 34385P108 | $256.7K | 311,967 | 0.0% |
| Adicet BIO Inc(ACET) | COM NEW | 007002207 | $196.8K | 22,779 | 0.0% |